Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Poultry Vaccines Market: By Vaccine, By Application, and Region Forecast 2019-2030
Poultry Vaccines Market size was valued at US$ 2.1 billion in 2023 and is expanded to grow at a significant CAGR of 5.9% from 2024-2030. The disease outbreaks in poultry drive the poultry vaccine market. Growing farmed poultry can speed up the spread of infectious pathogens among birds, such as the avian influenza virus, which has the great promise to cause widespread mortality and significant economic losses in poultry. However, poultry is accepted as a good source of protein. The poultry industry will be forced to intensify production in many countries, leading to more significant numbers of farms that house birds at elevated densities. Hence the regulatory bodies are accelerating the approval process for various vaccines related to veterinary health. Increasing awareness among veterinary practitioners about animal vaccination, growing meat consumption, and rising government initiatives for food safety is boosting the market. The growing poultry population, combined with the rising prevalence of avian diseases, will also drive market growth in the coming years.
Moreover, infected meat consumption risks human health, thereby making it imperative that the birds be vaccinated before usage. The main obstacles poultry farms face are the rapid spread of diseases and the lack of treatment options. To prevent such situations, vaccination becomes mandatory. In 2021, the attenuated live vaccines segment held the largest revenue share. Live attenuated vaccines' duration of immunity lasts longer and protects against avian diseases such as infectious bronchitis, infectious bursal disease, and Newcastle disease. Moreover, growing R&D activities, particularly in this field of vaccination, to curb various outbreaks of the diseases mentioned above are accentuating the segment growth.
Study Period
2024-2030Base Year
2023CAGR
5.9%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Across many parts of the world, the poultry industry is expanding and becoming more industrialized. Increased population, increased purchasing power, and urbanization have all been significant growth drivers. Furthermore, growing consumption of meat globally, initiatives are taken by the government, and increasing demand for poultry-related food products are the major factors driving the market's growth. Increasing use of antibiotics and illegal use of vaccines & backyard poultry will hamper the global industry.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2.1 billion |
Market CAGR |
5.9% |
By Vaccine Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
The global poultry vaccines market size was valued at US$ 2.1 billion in 2023 and is expected to grow at a significant CAGR of 5.9% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The market key players are Merck & Co., Inc., Elanco, Boehringer Ingelheim International GmbH, Biovac, Zoetis, Hester Biosciences Limited, KM Biologics, Phibro Animal Health Corporation
1.Executive Summary |
2.Global Poultry Vaccines Market Introduction |
2.1.Global Poultry Vaccines Market - Taxonomy |
2.2.Global Poultry Vaccines Market - Definitions |
2.2.1.Vaccine Type |
2.2.2.Application |
2.2.3.Region |
3.Global Poultry Vaccines Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Poultry Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Poultry Vaccines Market By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Inactivated Vaccines |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Live Attenuated Vaccines |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Poultry Vaccines Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Mareks Disease |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Newcastle Disease |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Infectious Bursal Disease |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Infectious Bronchitis |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Avian Influenza |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Coccidiosis |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Mycoplasma |
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Others |
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
7.Global Poultry Vaccines Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Inactivated Vaccines |
8.1.2.Live Attenuated Vaccines |
8.1.3.Others |
8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Mareks Disease |
8.2.2.Newcastle Disease |
8.2.3.Infectious Bursal Disease |
8.2.4.Infectious Bronchitis |
8.2.5.Avian Influenza |
8.2.6.Coccidiosis |
8.2.7.Mycoplasma |
8.2.8.Others |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Inactivated Vaccines |
9.1.2.Live Attenuated Vaccines |
9.1.3.Others |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Mareks Disease |
9.2.2.Newcastle Disease |
9.2.3.Infectious Bursal Disease |
9.2.4.Infectious Bronchitis |
9.2.5.Avian Influenza |
9.2.6.Coccidiosis |
9.2.7.Mycoplasma |
9.2.8.Others |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Inactivated Vaccines |
10.1.2.Live Attenuated Vaccines |
10.1.3.Others |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Mareks Disease |
10.2.2.Newcastle Disease |
10.2.3.Infectious Bursal Disease |
10.2.4.Infectious Bronchitis |
10.2.5.Avian Influenza |
10.2.6.Coccidiosis |
10.2.7.Mycoplasma |
10.2.8.Others |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Inactivated Vaccines |
11.1.2.Live Attenuated Vaccines |
11.1.3.Others |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Mareks Disease |
11.2.2.Newcastle Disease |
11.2.3.Infectious Bursal Disease |
11.2.4.Infectious Bronchitis |
11.2.5.Avian Influenza |
11.2.6.Coccidiosis |
11.2.7.Mycoplasma |
11.2.8.Others |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Inactivated Vaccines |
12.1.2.Live Attenuated Vaccines |
12.1.3.Others |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Mareks Disease |
12.2.2.Newcastle Disease |
12.2.3.Infectious Bursal Disease |
12.2.4.Infectious Bronchitis |
12.2.5.Avian Influenza |
12.2.6.Coccidiosis |
12.2.7.Mycoplasma |
12.2.8.Others |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Merck & Co., Inc., |
13.2.2.Elanco |
13.2.3.Boehringer Ingelheim International GmbH |
13.2.4.Biovac |
13.2.5.Zoetis |
13.2.6.Hester Biosciences Limited |
13.2.7.KM Biologics |
13.2.8.Phibro Animal Health Corporation |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players